Kamada Ltd. (KMDA) vs Tilray Brands, Inc. (TLRY)
Kamada Ltd. and Tilray Brands, Inc. are both Drug Manufacturers Specialty & Generic companies. Tilray Brands, Inc. is the larger, with a market value of $603.0M against $509.4M — 1.2× the size. Tilray Brands, Inc. has negative trailing earnings, so its P/E is not meaningful; Kamada Ltd. trades at 22.9×. Kamada Ltd. grew revenue faster over the last twelve months: 13.2% against 11.5%. Kamada Ltd. has the higher net margin (11.6% vs −13.3%) and the higher return on invested capital (8.47% vs −2.27%). Across the 20 metrics below, Kamada Ltd. leads on 15 and Tilray Brands, Inc. on 5.
Valuation
Profitability
| Metric | KMDA | TLRY | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 40.82% | 28.45% | 53.94% |
| Operating margin | 14.51% | (6.88%) | 0.00% |
| Net margin | 11.60% | (13.26%) | 0.00% |
| Free cash flow margin | 13.72% | (10.77%) | 0.00% |
| Return on equity | 8.40% | (7.87%) | (0.40%) |
| Return on assets | 5.92% | (5.52%) | (3.32%) |
| Return on invested capital | 8.47% | (2.27%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack